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Abstract
Background: Tubulin is a major substrate of the cytoplasmic class II histone deacetylase HDAC6. Inhibition of HDAC6 results
in higher levels of acetylated tubulin and enhanced binding of the motor protein kinesin-1 to tubulin, which promotes
transport of cargoes along microtubules. Microtubule-dependent intracellular trafficking may therefore be regulated by
modulating the activity of HDAC6. We have shown previously that the neuromodulator serotonin increases mitochondrial
movement in hippocampal neurons via the Akt-GSK3b signaling pathway. Here, we demonstrate a role for HDAC6 in this
signaling pathway.
Methodology/Principal Findings: We found that the presence of tubacin, a specific HDAC6 inhibitor, dramatically
enhanced mitochondrial movement in hippocampal neurons, whereas niltubacin, an inactive tubacin analog, had no effect.
Compared to control cultures, higher levels of acetylated tubulin were found in neurons treated with tubacin, and more
kinesin-1 was associated with mitochondria isolated from these neurons. Inhibition of GSK3b decreased cytoplasmic
deacetylase activity and increased tubulin acetylation, whereas blockade of Akt, which phosphorylates and down-regulates
GSK3b, increased cytoplasmic deacetylase activity and decreased tubulin acetylation. Concordantly, the administration of 5-
HT, 8-OH-DPAT (a specific 5-HT1A receptor agonist), or fluoxetine (a 5-HT reuptake inhibitor) increased tubulin acetylation.
GSK3b was found to co-localize with HDAC6 in hippocampal neurons, and inhibition of GSK3b resulted in decreased
binding of antibody to phosphoserine-22, a potential GSK3b phosphorylation site in HDAC6. GSK3b may therefore regulate
HDAC6 activity by phosphorylation.
Conclusions/Significance: This study demonstrates that HDAC6 plays an important role in the modulation of mitochondrial
transport. The link between HDAC6 and GSK3b, established here, has important implications for our understanding of
neurodegenerative disorders. In particular, abnormal mitochondrial transport, which has been observed in such disorders as
Alzheimer’s disease and Parkinson’s disease, could result from the misregulation of HDAC6 by GSK3b. HDAC6 may therefore
constitute an attractive target in the treatment of these disorders.
Citation: Chen S, Owens GC, Makarenkova H, Edelman DB (2010) HDAC6 Regulates Mitochondrial Transport in Hippocampal Neurons. PLoS ONE 5(5): e10848.
doi:10.1371/journal.pone.0010848
Editor: Colin Combs, University of North Dakota, United States of America
Received December 30, 2009; Accepted April 26, 2010; Published May 26, 2010
Copyright:  2010 Chen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The work was supported by the Neurosciences Research Foundation. The Neurosciences Research Foundation did not have any role in study design
and conduct of the study, the collection, analysis, and interpretation of the data, or the preparation, review, or approval of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: schen@nsi.edu
Introduction
Histone deacetylase 6 (HDAC6) is a predominantly cytoplasmic
class II histone deacetylase that is involved in many cellular
processes, including degradation of misfolded proteins, cell
migration, and cell-cell interaction [1]. Tubulin is a major
substrate of HDAC6; inhibition of HDAC6 can dramatically
increase the acetylation of tubulin both in vitro and in vivo [2,3].
Recently, it was reported that increased tubulin acetylation in
neurons could promote polarized transport of the kinesin-1 cargo
protein JNK-interacting Protein 1 (JIP-1) by increasing the binding
of kinesin-1 to acetylated tubulin [4]. Moreover, Dompierre et al.
[5] found that inhibiting HDAC6 reversed the transport deficit in
a Huntington’s disease model by increasing the vesicular transport
of Brain-Derived Neurotrophic Factor (BDNF), another kinesin-1
cargo protein. The foregoing findings suggest that microtubule
acetylation and the activity of HDAC6 play important roles in
regulating the trafficking of intracellular cargoes transported by
kinesin-1. Since it is known that kinesin-1 is the motor protein
required for anterograde transport of mitochondria within axons
[6], we hypothesized that HDAC6 also regulates mitochondrial
trafficking in neurons.
Mitochondrial transport and distribution are very important for
proper neuronal function [6]. Abnormal mitochondrial transport
is often associated with neurodegenerative diseases, such as
Alzheimer’s disease, Parkinson’s disease, Huntington’s disease,
and Lou Gehrig’s disease [7,8,9]. Interestingly, reduced microtu-
bule acetylation and intracellular transport failure are regarded as
early pathogenic events in the progression of Alzheimer’s disease
[10,11].
In the present study, we show that specific inhibition of HDAC6
greatly enhances mitochondrial trafficking in cultured hippocam-
pal neurons. In previous studies, we found that inhibition of
Glycogen Synthase Kinase 3b (GSK3b) promoted mitochondrial
transport in hippocampal neurons [12,13]. Here, we demonstrate
that inhibition of HDAC6 affects mitochondrial trafficking in a
PLoS ONE | www.plosone.org 1 May 2010 | Volume 5 | Issue 5 | e10848manner similar to that of GSK3b inhibition. We also provide
evidence that GSK3b may directly regulate HDAC6.
Results
Inhibition of HDAC6 by tubacin greatly increases
mitochondrial movement
To determine whether HDAC6 activity affects mitochondrial
trafficking, we applied tubacin (20 mM), a specific HDAC6
inhibitor [14], to cultured hippocampal neurons and followed
the movement of fluorescently tagged mitochondria using time-
lapse fluorescence microscopy. We found that tubacin greatly
enhanced mitochondrial movement, as shown by the kymographs
in Fig. 1A (Movies S1, S2, S3). Both the number of moving
mitochondria and the average velocity increased following tubacin
treatment (Fig. 1D and G). Consistent with this finding, in neurons
treated with trichostatin A (TSA, 10 mM), a nonspecific HDAC
inhibitor that has been used previously to enhance the acetylation
of microtubules [4,5], there was a similar increase in mitochon-
drial motility (Fig. 1B, E, H and Movies S4, S5, S6). In contrast,
niltubacin (20 mM), a tubacin analog that neither inhibits HDAC6
nor enhances acetylation of microtubules [14], did not alter
mitochondrial movement (Fig. 1C, F, I and Movies S7, S8, S9).
Within the limits of our imaging technique, we did not observe any
changes in the morphology of mitochondria following exposure to
HDAC inhibitors.
Inhibition of HDAC6 increases acetylation of tubulin and
association of kinesin-1 with mitochondria in
hippocampal neurons
In agreement with an earlier report using non-neuronal cells
[14], Western blot analysis of acetylated tubulin in extracts from
hippocampal neurons showed that treatment with tubacin (20 mM)
increased levels of acetylated tubulin (Fig. 2A, lane 2). Treatment
with TSA (10 mM) had a similar effect (Fig. 2A, lane3) and, as
expected, the administration of niltubacin (20 mM) did not change
levels of tubulin acetylation, relative to controls (Fig. 2B, lane 2).
Total levels of kinesin-1B and tubulin were unaffected (Fig. 2A
and B).
We postulated that the observed increase in mitochondrial
movement resulting from HDAC6 inhibition would correlate with
increased levels of acetylated tubulin and kinesin-1 associated with
mitochondria. To measure both the level of acetylation of tubulin
and the amount of kinesin-1 associated with mitochondria, we
isolated mitochondria from hippocampal neurons that had been
treated with tubacin, TSA, or niltubacin. As shown by Western
blot analysis, inhibition of HDAC6 by tubacin increased the
amount of kinesin-1 associated with mitochondria compared to an
untreated control (Fig. 2E, lanes 1 and 2). Similarly, treatment
with TSA resulted in more kinesin-1 in the mitochondrial fraction
(Fig. 2E, lanes l and 3), whereas administration of niltubacin did
not cause a significant change compared to an untreated control
(Fig. 2F, lanes 1 and 2). It is likely that not all of the tubulins found
in the mitochondrial fractions are associated with organelles via
kinesin-1. Although we cannot completely exclude the possibility
of cytoplasmic contamination, it has been shown that a significant
amount of tubulin binds tightly to mitochondria via the voltage-
dependent anion channel [15].
Inhibition of GSK3b also increases acetylation of tubulin
in hippocampal neurons
In a previous study, we found that inhibition of GSK3b
dramatically stimulated mitochondrial movement [12]. The fact
that many substrates of GSK3b are cytoskeleton-related proteins
[16] prompted us to investigate the effects of GSK3b inhibition on
the acetylation of tubulin. We found that inhibiting GSK3b with
lithium chloride (LiCl, 10 mM) resulted in both an increase in the
level of acetylated tubulin and the amount of kinesin-1 associated
with mitochondria (Fig. 2B, lane 3; Fig. 2F, lane 3). These results
closely resemble the effects of inhibiting HDAC6 using tubacin or
TSA (Fig. 2A, lanes 2 and 3; Fig. 2E, lanes 2 and 3). Using two
different GSK3b inhibitors, we confirmed that blocking activity
greatly enhanced mitochondrial movement, as shown by the
kymographs presented in Fig. 3A and B (Movies S10, S11, S12,
S13, S14, S15). Quantification of the number of moving
mitochondria and average velocity are shown in Fig. 3C–F. In
parallel cultures, inhibition of GSK3b led to an approximately
60% increase in the acetylation of tubulin (Fig. 3G and H). In
contrast, levels of acetylated tubulin declined by approximately
40% when GSK3b activity was increased by inhibiting Akt activity
(Fig. 3I and J). These results are consistent with the idea that the
Akt-GSK3b signaling pathway may control mitochondrial move-
ment in neurons by modulating acetylation of microtubules via the
regulation of HDAC6.
Inhibition of GSK3b decreases the activity and protein
levels of HDAC6 in hippocampal neurons
HDAC6 is the only cytosolic enzyme known to cause the
deacetylation of tubulin in neurons [17]. We therefore investigated
whether inhibiting GSK3b would directly affect HDAC6 activity.
Whole cell lysates of hippocampal neurons, treated for one hour
with LiCl, SB216763, or an Akt inhibitor (Akt-i) were separated
into cytoplasmic and nuclear fractions. Total HDAC activity was
assayed in both fractions. Treatment with either of the GSK3b
inhibitors resulted in a slight decrease of HDAC6 protein level
(Fig. 4A, B). However, a marked decrease in deacetylase activity
was measured in the cytoplasmic fraction, but not in the
corresponding nuclear fraction (Figure 4C). In contrast, when
GSK3b activity was elevated by inhibiting Akt (Akt inhibitor VIII,
5 mM), the activity of HDAC6 was significantly increased (Fig. 4D),
a finding that is consistent with the Western blot analysis of tubulin
acetylation in hippocampal neurons shown in Figure 3I and J.
GSK3b regulates HDAC6 in situ
It has been shown that HDAC6 is a phosphoprotein [18,19],
but neither the kinases that are responsible for phosphorylating
HDAC6 nor the effect of phosphorylation on this deacetylase have
been established. Our finding, that GSK3b likely regulates
HDAC6 activity, suggests that HDAC6 is a substrate for GSK3b.
To test this idea, we first examined the localization of GSK3b and
HDAC6 in neurons by immuocytochemistry (Fig. 5A–D). Images
of co-immunostained hippocampal neurons acquired through
confocal microscopy revealed that GSK3b and HDAC6 were both
distributed throughout the cells (Fig. 5E and F). Moreover,
immunoprecipitation experiments showed that HDAC6 and
GSK3b were found in the same protein complex in hippocampal
neurons (Fig. 5G), suggesting that HDAC6 and GSK3b physically
interact with each other in situ. Various phosphorylation site
prediction methods have indicated that serine-22 in murine and
rat HDAC6 (corresponding to serine-21 in human HDAC6) may
be phosphorylated by GSK3b. Further, a genome-wide phospho-
protein survey has shown that this site on HDAC6 is phosphor-
ylated [18]. Using a commercially available antibody (Abcam,
ab61058, HDAC6-phospho S22), we found that inhibiting
GSK3b with SB216763 decreased the level of phospho S22
immunoreactivity in hippocampal neurons and concomitantly
increased the number of acetylated microtubules (Fig. 5H, I). In
HDAC6 and Mitochondria
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S22 and decreased acetylation of microtubules (Fig. 5H–J, K–M).
5-HT regulates acetylation of tubulin
We reported earlier that 5-HT promotes mitochondrial
transport in hippocampal neurons via the 5-HT1A receptor
[12]. Our finding, that either 5-HT or 8-OH-DPAT, a 5-HT1A
receptor agonist, could promote mitochondrial transport via the
Akt-GSK3b signaling pathway [12], led us to investigate whether
5-HT might also regulate the acetylation of tubulin. Western blot
analysis of acetylated tubulin showed that treatment with either 5-
HT or 8-OH-DPAT, significantly increased the amount of
acetylated tubulin in treated hippocampal neurons (Fig. 6A and
C). Similarly, increased levels of acetylated tubulin and kinesin-1
were found in mitochondrial fractions isolated from parallel
cultures that had also been treated with the same drugs (Fig. 6B
and D). Fluoxetine, a selective serotonin reuptake inhibitor, also
increased both the acetylation of tubulin (Fig. 6E and G) and the
association of kinesin-1 with mitochondria (Fig. 6F and H). We
suggest that 5-HT promotes axonal transport of mitochondria in a
manner similar to that of HDAC6 inhibition.
GSK3b is known to phosphorylate the kinesin light chain, and
inhibit axonal transport [20]. We probed lysates and purified
mitochondria from 5-HT-treated and control cultures with
antibodies directed against the kinesin light chains (KLC1 and
KLC2). No light chains were detected in the mitochondrial
fractions, suggesting that any effect of GSK3b on mitochondrial
movement in hippocampal neurons does not involve phosphory-
lation of these kinesin light chains (Figure S1).
Discussion
Specific inhibition of HDAC6 leads to increased
mitochondrial motility
Mitochondrial transport is critical for proper neuronal function
[6]. Within axons, mitochondria, like other cargoes, are known to
be carried along microtubules by molecular motor proteins such as
kinesin and dynein [6]. However, the means by which the
interaction between mitochondria and the transport machinery is
regulated, and the links to particular signals that affect the
movement of mitochondria are not fully understood. Recently, it
was shown that acetylation of tubulin promotes the trafficking of
kinesin-1 dependent cargoes such as JIP-1 and BDNF [4,5]. This
was demonstrated by preventing tubulin deacetylation with
tubacin, a specific HDAC6 inhibitor. In the presence of the same
inhibitor, we increased acetylation of tubulin in cultured
hippocampal neurons, and found that this correlated with
increased rates of mitochondrial transport. Although it remains
unclear how the acetylation of tubulin enhances the movement of
cargoes on microtubules, there is evidence that acetylation
increases the interaction between tubulin and such motor proteins
as kinesin-1 and dynein [4,5,21]. It is possible that acetylated
microtubules act as higher-affinity tracks for mitochondrial
movement, and therefore reduce the need for mitochondria to
switch tracks during transport. Such enhanced interaction between
microtubules and motor protein might explain the extended
episodes of motility that we observed in our experiments. By
fractionating cytoplasmic extracts of tubacin-treated cultures, we
found that greater amounts of acetylated tubulin and kinesin-1
were associated with mitochondria following exposure to tubacin.
Since kinesin-1 is not an exclusively mitochondrial motor protein,
it is likely that the observed effect of increased acetylation of
microtubules on mitochondrial movement produced by inhibiting
HDAC6 is a reflection of a more general promotion of
intracellular cytoplasmic trafficking within neurons. Consistent
with this idea, it was recently reported that inhibition of HDAC6
produced a higher transfection efficiency by enhancing intracel-
lular transport of transfected plasmids [22].
Is tubulin deacetylation the only way in which HDAC6
regulates mitochondrial trafficking?
In addition to tubulin, HDAC6 is associated with many other
proteins [1]. At present, it is not certain whether other substrates of
HDAC6 are involved in the enhancement of mitochondrial
trafficking that we have observed. Under pathological circum-
stances, the effect of HDAC6 on the degradation of misfolded-
protein may also be involved in mitochondrial trafficking. HDAC6
has been found in aggresomes containing dynein and other
proteins [23]. The formation of aggresomes might play a role in
mitochondrial movement regulated by HDAC6. Indeed, it was
recently reported that protein trafficking of both Parkin and DJ-1
aggresomes were directly involved in HDAC6 inhibition [24,25].
Moreover, the cdc20-APC aggresome complex was also shown to
be involved in direct binding to HDAC6, as well as neuronal
dendritic morphogenesis [26]. Taken together, the foregoing
suggests that protein degradation might play a role in the
regulation of intracellular trafficking. The intricate relationship
between HDAC6-related protein degradation and mitochondrial
trafficking merits further study.
In a recent genome-wide RNAi screen of Drosophila melanogaster,
HDAC6 was identified as a modulator of mitochondrial function,
suggesting not only that it may exert a major influence on
mitochondrial trafficking, but also that it may have a profound
effect on overall mitochondrial function [27].
The function of HDAC6 phosphorylation
Using a phosphoepitope-specific antibody, we showed that
phosphorylation of HDAC6 at serine-22, which conforms to the
consensus site for GSK3b phosphorylation, was reduced by
modulating GSK3b activity (Fig. 5H–J). This suggests that GSK3b
may directly phosphorylate HDAC6 at this site, although further
work with purified proteins is needed to determine whether this is
the case. Since some other kinases share the same consensus
phosphorylation site with GSK3b—for example cdk5 and p38—
HDAC6 may also be simultaneously regulated by other kinases via
phosphorylation of serine-22.
We observed that inhibiting GSK3b decreased overall deace-
tylase activity in cytoplasmic extracts of hippocampal neurons, but
not in the corresponding nuclear fractions, suggesting that the
effect is quite specific (Fig. 4B). The fact that HDAC6 is the
predominant cytoplasmic deacetylase in neurons [1] suggests that
GSK3b-dependent phosphorylation may enhance HDAC6 activ-
Figure 1. Inhibition of HDAC6 by tubacin dramatically promotes mitochondrial movement in hippocampal neurons. Kymographs (A,
B and C) depicting mitochondrial motility were made from Movies S1, S2, S3, S4, S5, S6, and S7, S8, S9 respectively. In the experiment, a segment of
axon was imaged continuously for 3 hours with a short break to allow for administration of drugs. Images were acquired at 10-second intervals. A.
Treatment with tubacin. B. Treatment with TSA. C. Treatment with niltubacin. D, E and F. Quantification of the numbers of moving mitochondrial
during the period of observation (n=6). Only mitochondria that moved through the entire field of view were counted. G, H and I. Quantification of
mean velocities of moving mitochondria (n=5).
doi:10.1371/journal.pone.0010848.g001
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inhibition of both mitochondrial motility and the transport of
other kinesin-1 dependent cargoes. Conversely, the activation of
Akt—for example, by exposure to serotonin with consequent
phosphorylation and inhibition of GSK3b—would lead to a
decrease in HDAC6 activity, higher levels of tubulin acetylation,
and increased movement of mitochondria.
Kinesins bind to various cargoes via several different adaptor
proteins [28]. Kinesin light chains comprise an important class of
adaptor proteins that associate with kinesin-1, and mediate fast
Figure 2. Changes in tubulin acetylation and association of kinesin-1B with mitochondria occur following treatment with tubacin,
TSA, or LiCl. A. Western blot analysis of kinesin-1B and acetylated tubulin levels in total cell lysates from hippocampal neuronal cultures that were
treated with tubacin (20 mM) or TSA (10 mM) for one hour. B. Western blot analysis of kinesin-1B and acetylated tubulin levels in total cell lysates from
hippocampal neuronal cultures that were treated with niltubacin (20 mM) or LiCl (10 mM) for one hour. C. Quantification of Western blot results
shown in A (n=3). D. Quantification of Western blot results shown in B (n=3). E. Western blot analysis of kinesin1-B and acetylated tubulin protein
levels in a mitochondrial fraction isolated from hippocampal neuronal cultures that were treated with tubacin (20 mM) or TSA (10 mM) for one hour. F.
Western blot analysis of kinesin1-B and acetylated tubulin protein levels in a mitochondrial fraction from hippocampal neuronal cultures that were
treated with niltubacin (20 mM) or LiCl (10 mM) for one hour. G. Quantification of Western blot results shown in E (n=3). H. Quantification of Western
blot results shown in F (n=3). Mitochondrial protein levels were normalized to voltage-dependent anion channel (VDAC) protein levels.
doi:10.1371/journal.pone.0010848.g002
HDAC6 and Mitochondria
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ylates kinesin light chain 2 (KLC2), and negatively regulates
anterograde axonal transport [20]. In the present work, we did not
detect KLC1 nor KLC2, the major KLCs [30], in fractions of
mitochondria isolated from hippocampal neurons. Work by others
has indicated that KLCs may not be the predominant adaptor
protein that links kinesin-1 to mitochondria [31,32,33,34]. In
Drosophila, the proteins Milton and dMiro are critical to transport
of mitochondria in neurons, and mammalian homologues of these
proteins (GRIF-1 and Miro1) have been shown mediate transport
of mitochondria [34]. Moreover, in a recent study of the transport
of Na, K-ATPase-containing vesicles, mitochondrial motility was
not affected by knock-down of KLC2 by shRNA [35]. These
observations are consistent with the idea that GSK3b regulates
mitochondrial transport by acting through HDAC6, independent
of KLCs.
Potential implications for disease and therapy
The present study suggests that GSK3b inhibition and HDAC6
activity are closely linked. A number of anti-depressant medica-
tions act directly or indirectly to block GSK3b activity. For
example, LiCl is known to inhibit GSK3b, and we have previously
shown that the selective serotonin reuptake inhibitor, fluoxetine,
decreases GSK3b activity by upregulating Akt [12]. It is
conceivable that these drugs ultimately act to counter depression
via a common downstream mechanism: namely the modulation of
HDAC6 activity. The regulation of HDAC6 would affect
intracellular trafficking of both organelles and proteins in neurons
through changes in levels of acetylated tubulin. It is important to
note that HDAC6 is also involved in other important cellular
processes, serving in some instances as a stress response ‘central
node’ [36] and in others as a cellular redox state sensor [37]. In
any case, many of the molecular effects of HDAC6 impact the
structure and function of microtubules and actin filaments, both of
which are critical to intracellular trafficking.
It was reported recently that HDAC6 exhibits increased activity
in cerebral cortex and hippocampus of Alzheimer’s disease
patients [38]. This finding is consonant with the observed
reduction of acetylated tubulin in affected neurons from
Alzheimer’s disease patients [10], and may further strengthen
the link between mitochondrial movement and this disorder.
Given these observations, it is possible that the reported
perturbation of mitochondrial transport associated with Alzhei-
mer’s disease is caused by an elevated level of HDAC6 and a
consequent alteration of the cellular trafficking machinery.
Moreover, it is possible that, in Alzheimer’s disease, aberrant
HDAC6 levels are induced by increased activity of GSK3b [39].
The present study not only supports the importance of GSK3
Figure 3. GSK3b activity regulates both mitochondrial movement and tubulin acetylation. Inhibition of GSK3b by LiCl or SB216763
promotes mitochondrial movement and increases levels of acetylated tubulin, whereas activation of GSK3b via inhibition of Akt decreases levels of
acetylated tubulin in hippocampal neurons. Kymographs (A and B) of mitochondrial motility correspond to Movies S10, S11, S12 and S13, S14, S15
respectively. In the experiment, a segment of axon was imaged continuously for 3 hours with short break to administer drugs. Images were acquired
at 10-second intervals. A. Treatment with LiCl. B. Treatment with SB216763. C and D. Quantification of the numbers of moving mitochondria during
the period of observation (n=5). Only mitochondria that moved through the entire field of view were calculated. E and F. Quantification of mean
velocities of moving mitochondria (n=5). G. Western blot analysis of acetylated tubulin in extracts from hippocampal neurons that were treated with
LiCl or SB216763. H. Quantification of Western blot shown in G. I. Western blot analysis of acetylated tubulin, phosphorylated Akt (pAkt), and
phosphorylated GSK3b (pGSK3b) in extracts from hippocampal neurons that were treated with Akt inhibitor. J. Quantification of Western blot shown
in I.
doi:10.1371/journal.pone.0010848.g003
Figure 4. Inhibition of GSK3b decreases protein levels and activity of HDAC6 in hippocampal neurons. A. Western blot analysis of
protein levels of HDAC6 in hippocampal neurons that were treated with LiCl (10 mM) or SB216763 (2 mM) for one hour. B. Quantification of Western
blot shown in A (n=3). C. HDAC6 activity assay of total protein lysate from hippocampal neurons that were treated with LiCl (10 mM) or SB216763
(2 mM) for one hour. D. HDAC6 activity assay of total protein lysate from hippocampal neurons that were treated with Akt inhibitor VIII (5 mM) for one
hour. Efficiencies of the separation of cytoplasmic and nuclear phases in C and D are shown by Western blot using anti-GAPDH antibodies.
doi:10.1371/journal.pone.0010848.g004
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PLoS ONE | www.plosone.org 7 May 2010 | Volume 5 | Issue 5 | e10848Figure 5. HDAC6 and GSK3b are co-localized in hippocampal neurons; HDAC6 serine-22 phosphorylation levels are modulated by
GSK3b. A–F. Immunostaining of HDAC6 and GSK3b in hippocampal neurons. F. Plot of co-localization generated from confocal image data collected
from four neurons (six Z levels per cell; total sample size ,24). G. Immunoprecipitation of GSK3b and HDAC6, respectively. H–J. Confocal images of
immunostained acetylated tubulin and phosphorylated HDAC6 (anti-phosphoserine 22) in hippocampal neurons. H. Before treatment. I. After
treatment with SB216763. J. After treatment with Akt inhibitor VIII (5 mM). K, L and M. Quantification of images H–J. Mean values of relative pixel
intensities are shown.
doi:10.1371/journal.pone.0010848.g005
HDAC6 and Mitochondria
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progression of Alzheimer’s disease [40], but also emphasizes the
central role of GSK3 in regulating intracellular trafficking
[41,42,43].
Materials and Methods
Primary cell culture and infection of cell culture
Preparation of hippocampal neuronal cultures and infection
with the MitoTurboRFP lentivirus were as previously described
[12,13].
Live cell imaging and image analysis
To provide life support for primary neuronal cultures during
extended imaging sessions, we used a microscope stage-top
incubator that we designed and built to enclose a 35 mm glass-
bottom culture dish. The stage-top incubator chamber is
connected, through a closed circuit of silicon hoses, to a Forma
Model 3154 water-jacketed incubator (Thermo Fisher Scientific,
Inc., Waltham, MA) that supplies an atmosphere of 90% air/10%
CO2. Ambient air and stage temperatures are maintained at 37uC
via thermostat-controlled resistors mounted both inside the stage-
top incubator chamber and on its aluminum base. Fluorescence
microscopy was used to observe axonal transport of MitoTur-
boRed-labeled mitochondria in live hippocampal neurons. Time-
lapse image series were acquired under high magnification (636
PLAN APO oil immersion objective; numerical aperture=1.32;
Leica, GmbH, Germany) using a Leica DMI-6000B inverted
fluorescence microscope (Leica GmbH, Germany) equipped with
a Sutter Lamda 10-2 emission filter wheel, Sutter DG-4 xenon
light source (Sutter Instruments, Novato, CA), and a Cooke
Sensiscam qe
TM cooled CCD camera (Cooke Corporation,
Romulus, MI). Microscope control and image capture and
analysis were accomplished using the Slidebook
TM image
acquisition and analysis software package (Intelligent Imaging
Innovations, Inc., Denver, CO). In each imaging session,
individual frames of mitochondria within an axon segment were
acquired every 10 seconds (except where noted) for a total
recording time of one hour. Kymographs were generated by the
‘smooth curve analysis’ module in Slidebook
TM. Confocal images
were acquired with a Zeiss LSM 710 laser confocal microscope
(Karl Zeiss, Microimaging, GmbH, Germany). Confocal data was
analyzed using Imaris software package (Bitplane Inc., Saint Paul,
MN).
Immunocytochemical staining and reagents
Details of immunostaining protocols used in the present study
can be found in a previous publication [13]. HDAC6 antibodies
were purchased from Abcam (Cambridge, MA), Santa Cruz
Biotechnology (Santa Cruz, CA), and Cell Signaling (Denvers,
MA). GSK3b antibodies were purchased from Cell Signaling
(Denver, MA). Acetylated tubulin antibodies were purchased from
Sigma (St. Louis, MO). Tubacin and niltubacin were kindly
provided by Dr. Stuart Schreiber of Harvard University. Akt
inhibitor VIII was purchased from Calbiochem (La Jolla, CA). All
Figure 6. 5-HT signals increase levels of Kinesin-1B and acetylated tubulin in mitochondrial fractions isolated from hippocampal
neurons. A, C. 5-HT or 8-OH-DPAT increases acetylation of tubulin in hippocampal neurons. B, D. Fluoxetine increases acetylation of tubulin in
hippocampal neurons. E, F, G, H. 5-HT, 8-OH-DPAT, or fluoxetine increase the amount of kinesin1-B (top panel) and acetylated tubulin (bottom panel)
found in a mitochondrially-enriched fraction. Mitochondrial protein levels were normalized to VDAC. Quantifications of Western blots were based on
multiple experiments (n$3).
doi:10.1371/journal.pone.0010848.g006
HDAC6 and Mitochondria
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MO) if not otherwise specified.
Western blotting
Details of the Western blot protocol used in the present study
can be found in a previous publication [13].
Isolation of mitochondria
Mitochondrial fractions were isolated from rat hippocampal
neuronal cultures following the ‘sucrose gradient separation
protocol’ developed by Mitosciences, Inc. (Eugene, OR).
Activity assay of HDAC6
Basic procedures were performed according to product
instructions included with the HDAC activity fluorometric assay
kit used (Biomol, Plymouth Meeting, PA). When samples were
detected, the wavelength of excitation was 460 nm and the
detected wavelength of emission was 360 nm (gain=850). In the
assay for HDAC6 activity, protein extracts from whole cell lysates
of hippocampal neurons were separated into cytoplasmic and
nuclear phases using a corresponding product from Pierce
(Rockford, IL).
Supporting Information
Figure S1 Kinesin light chains (KLCs) do not copurify with
mitochondria isolated from hippocampal neurons. Western blot
analysis of lysates and mitochondrial fractions from 5-HT-treated
and control cultures. Protein extracts were probed with kinesin-1B,
kinesin light chain 1 (KLC1), kinesin light chain 2 (KLC2) and b-
actin antibodies.
Found at: doi:10.1371/journal.pone.0010848.s001 (0.16 MB TIF)
Movie S1 Mitochondrial motility before treatment with tubacin.
Time-lapse series showing motility of MitoTurboRFP-labeled
mitochondria in cultured hippocampal neurons for one hour
before administration of tubacin.
Found at: doi:10.1371/journal.pone.0010848.s002 (3.00 MB
MOV)
Movie S2 Mitochondrial motility after treatment with tubacin.
Time-lapse series showing motility of MitoTurboRFP-labeled
mitochondria in cultured hippocampal neurons for first hour after
administration of tubacin.
Found at: doi:10.1371/journal.pone.0010848.s003 (3.11 MB
MOV)
Movie S3 Mitochondrial motility after treatment with tubacin.
Time-lapse series showing motility of MitoTurboRFP-labeled
mitochondria in cultured hippocampal neurons for second hour
after administration of tubacin.
Found at: doi:10.1371/journal.pone.0010848.s004 (3.19 MB
MOV)
Movie S4 Mitochondrial motility before treatment with TSA.
Time-lapse series showing motility of MitoTurboRFP-labeled
mitochondria in cultured hippocampal neurons for one hour
before administration of TSA.
Found at: doi:10.1371/journal.pone.0010848.s005 (0.66 MB
MOV)
Movie S5 Mitochondrial motility after treatment with TSA.
Time-lapse series showing motility of MitoTurboRFP-labeled
mitochondria in cultured hippocampal neurons for first hour after
administration of TSA.
Found at: doi:10.1371/journal.pone.0010848.s006 (2.96 MB
MOV)
Movie S6 Mitochondrial motility after treatment with TSA.
Time-lapse series showing motility of MitoTurboRFP-labeled
mitochondria in cultured hippocampal neurons for second hour
after administration of TSA.
Found at: doi:10.1371/journal.pone.0010848.s007 (0.75 MB
MOV)
Movie S7 Mitochondrial motility before treatment with niltu-
bacin. Time-lapse series showing motility of MitoTurboRFP-
labeled mitochondria in cultured hippocampal neurons for one
hour before administration of niltubacin.
Found at: doi:10.1371/journal.pone.0010848.s008 (1.98 MB
MOV)
Movie S8 Mitochondrial motility after treatment with niltuba-
cin. Time-lapse series showing motility of MitoTurboRFP-labeled
mitochondria in cultured hippocampal neurons for first hour after
administration of niltubacin.
Found at: doi:10.1371/journal.pone.0010848.s009 (1.34 MB
MOV)
Movie S9 Mitochondrial motility after treatment with niltuba-
cin. Time-lapse series showing motility of MitoTurboRFP-labeled
mitochondria in cultured hippocampal neurons for second hour
after administration of niltubacin.
Found at: doi:10.1371/journal.pone.0010848.s010 (1.01 MB
MOV)
Movie S10 Mitochondrial motility before treatment with LiCl.
Time-lapse series showing motility of MitoTurboRFP-labeled
mitochondria in cultured hippocampal neurons for one hour
before administration of LiCl.
Found at: doi:10.1371/journal.pone.0010848.s011 (1.29 MB
MOV)
Movie S11 Mitochondrial motility after treatment with LiCl.
Time-lapse series showing motility of MitoTurboRFP-labeled
mitochondria in cultured hippocampal neurons for first hour after
administration of LiCl.
Found at: doi:10.1371/journal.pone.0010848.s012 (1.29 MB
MOV)
Movie S12 Mitochondrial motility after treatment with LiCl.
Time-lapse series showing motility of MitoTurboRFP-labeled
mitochondria in cultured hippocampal neurons for scond hour
after administration of LiCl.
Found at: doi:10.1371/journal.pone.0010848.s013 (1.76 MB
MOV)
Movie S13 Mitochondrial motility before treatment with
SB216763. Time-lapse series showing motility of MitoTur-
boRFP-labeled mitochondria in cultured hippocampal neurons
for one hour before administration of SB216763.
Found at: doi:10.1371/journal.pone.0010848.s014 (1.21 MB
MOV)
Movie S14 Mitochondrial motility after treatment with
SB216763. Time-lapse series showing motility of MitoTur-
boRFP-labeled mitochondria in cultured hippocampal neurons
for first hour after administration of SB216763.
Found at: doi:10.1371/journal.pone.0010848.s015 (1.76 MB
MOV)
Movie S15 Time-lapse series showing motility of MitoTur-
boRFP-labeled mitochondria in cultured hippocampal neurons for
second hour after administration of SB216763.
Found at: doi:10.1371/journal.pone.0010848.s016 (2.57 MB
MOV)
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